BiotechTube
Home/Longeveron/Wa'el Hashad
WH

Wa'el Hashad

Chief Executive Officer

Longeveron

Therapeutic Areas

CardiologyNeurologyGeriatrics

Longeveron Pipeline

DrugIndicationPhase
Laromestrocel (Lomecel-B™)Hypoplastic Left Heart Syndrome (HLHS)Phase 2b

Leadership Team at Longeveron

CM
Chris Min, M.D., Ph.D.
Chief Medical Officer
JH
Joshua Hare, M.D.
Co-founder, Chief Science Officer, Chairman
LA
Lisa A. Michaels, M.D.
Chief Regulatory Officer
JB
Jerome Bailey
Vice President of Business Operations
RK
Richard Kender
Board Member
UU
Ursula Ungaro
Board Member
View full Longeveron profile